Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Graham

Showing results (1251-1260 of 1,460) with videos related to

Pageof 146
Sort By:
Lancet (London, England)|August 19, 2014
Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trialLee-Jah Chang, Kimberly A Dowd, Floreliz H Mendoza, et al.
Cell Reports|November 24, 2024
Modulating the immunodominance hierarchy of immunoglobulin germline-encoded structural motifs targeting the influenza hemagglutinin stemSila Ataca, Maya Sangesland, Rebeca de Paiva Fróes Rocha, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2010
Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of CongoAnne W Rimoin, Prime M Mulembakani, Sara C Johnston, et al.
NPJ Vaccines|December 22, 2017
An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trialAdam D DeZure, Emily E Coates, Zonghui Hu, et al.
The Journal of Infectious Diseases|February 18, 1998
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection GroupB S Graham, M J McElrath, R I Connor, et al.
Bioconjugate Chemistry|September 2, 2016
Thermoresponsive Polymer Nanoparticles Co-deliver RSV F Trimers with a TLR-7/8 AdjuvantJoseph R Francica, Geoffrey M Lynn, Richard Laga, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Optimal symptom combinations to aid COVID-19 case identification: analysis from a community-based, prospective, observational cohortM Antonelli, J Capdevila, A Chaudhari, et al.
The Journal of Infection|February 16, 2021
Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohortM Antonelli, J Capdevila, A Chaudhari, et al.
Nature Communications|October 4, 2023
Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgeneraGeoffrey B Hutchinson, Olubukola M Abiona, Cynthia T Ziwawo, et al.
Global Change Biology|October 4, 2019
Trends in tuna carbon isotopes suggest global changes in pelagic phytoplankton communitiesAnne Lorrain, Heidi Pethybridge, Nicolas Cassar, et al.
Pageof 146

Showing results (1251-1260 of 1,460) with videos related to

Sort By:
Pageof 146
Lancet (London, England)|August 19, 2014
Safety and tolerability of chikungunya virus-like particle vaccine in healthy adults: a phase 1 dose-escalation trialLee-Jah Chang, Kimberly A Dowd, Floreliz H Mendoza, et al.
Cell Reports|November 24, 2024
Modulating the immunodominance hierarchy of immunoglobulin germline-encoded structural motifs targeting the influenza hemagglutinin stemSila Ataca, Maya Sangesland, Rebeca de Paiva Fróes Rocha, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2010
Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of CongoAnne W Rimoin, Prime M Mulembakani, Sara C Johnston, et al.
NPJ Vaccines|December 22, 2017
An avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trialAdam D DeZure, Emily E Coates, Zonghui Hu, et al.
The Journal of Infectious Diseases|February 18, 1998
Analysis of intercurrent human immunodeficiency virus type 1 infections in phase I and II trials of candidate AIDS vaccines. AIDS Vaccine Evaluation Group, and the Correlates of HIV Immune Protection GroupB S Graham, M J McElrath, R I Connor, et al.
Bioconjugate Chemistry|September 2, 2016
Thermoresponsive Polymer Nanoparticles Co-deliver RSV F Trimers with a TLR-7/8 AdjuvantJoseph R Francica, Geoffrey M Lynn, Richard Laga, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Optimal symptom combinations to aid COVID-19 case identification: analysis from a community-based, prospective, observational cohortM Antonelli, J Capdevila, A Chaudhari, et al.
The Journal of Infection|February 16, 2021
Optimal symptom combinations to aid COVID-19 case identification: Analysis from a community-based, prospective, observational cohortM Antonelli, J Capdevila, A Chaudhari, et al.
Nature Communications|October 4, 2023
Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive antibody response against diverse coronavirus subgeneraGeoffrey B Hutchinson, Olubukola M Abiona, Cynthia T Ziwawo, et al.
Global Change Biology|October 4, 2019
Trends in tuna carbon isotopes suggest global changes in pelagic phytoplankton communitiesAnne Lorrain, Heidi Pethybridge, Nicolas Cassar, et al.
Pageof 146